Rep. Josh Gottheimer sold Syneos Health (SYNH)
Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Jan 23, 2023
- Transaction
- Sold
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Jan 23, 2023
- Disclosed
- Feb 17, 2023
- Days to disclose
- 25
- Asset type
- Stock
- As filed
- Syneos Health, Inc. - Class A
- Industry
- Medical - Diagnostics & Research · Healthcare
Other trades in this filing
All of Gottheimer's trades →- Feb 17, 2023$1K–$15K
Sold (partial) UnitedHealth Group UNH
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
Got $20K from the company’s PAC - Feb 17, 2023$1K–$15K
Sold (partial) United Parcel Service UPS
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
Got $10K from the company’s PAC - Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
Got $4K from the company’s PAC - Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
Got $3K from the company’s PAC - Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
Sold International Business Machines IBM
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
Got $10K from the company’s PAC - Feb 17, 2023$1K–$15K
Sold (partial) The Coca-Cola Company KO
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
Sold (partial) Automatic Data Processing ADP
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 27, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 27, 2023 · disclosed Feb 17, 2023 · Joint
Got $4K from the company’s PAC - Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 27, 2023 · disclosed Feb 17, 2023 · Joint
Got $4K from the company’s PAC - Feb 17, 2023$1K–$15K
$1K–$15K · Traded Jan 27, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
Sold (partial) HCA Healthcare HCA
$1K–$15K · Traded Jan 27, 2023 · disclosed Feb 17, 2023 · Joint
- Feb 17, 2023$1K–$15K
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Jan 27, 2023 · disclosed Feb 17, 2023 · Joint
Got $10K from the company’s PAC
Recent Congress trades in SYNH
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
- Jan 13, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (partial) Syneos Health SYNH
$1K–$15K · Traded Dec 6, 2022 · disclosed Jan 13, 2023 · Joint
Company context for SYNH
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
SYNH: third_quarter 2026 lobbying report
Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; issues related to research and development.
Public: Oct 20, 2026, 5:31 PM EDTOriginal source ↗SYNH: second_quarter 2026 lobbying report
Clinical trials and research. Remote clinical trials, biomedical research & development. Business and corporate tax issues, international tax reform; issues related to research and development.
Public: Jul 20, 2026, 3:25 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.